Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
148.67
+1.67 (1.14%)
Mar 4, 2026, 12:04 PM EST - Market open
Insmed Analyst Ratings
Total Analysts
23
Consensus Rating
Strong Buy
Price Target
$188.73
Upside
+26.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $211 → $204 | Buy | Maintains | $211 → $204 | +37.22% | Feb 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $230 | Strong Buy | Reiterates | $230 | +54.71% | Feb 23, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $234 → $208 | Buy | Maintains | $234 → $208 | +39.91% | Feb 20, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $157 → $162 | Hold | Maintains | $157 → $162 | +8.97% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $231 | Buy | Initiates | $231 | +55.38% | Jan 28, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $212 | Strong Buy | Initiates | $212 | +42.60% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $197 → $200 | Buy | Maintains | $197 → $200 | +34.53% | Jan 21, 2026 |
| UBS | UBS | Strong Buy Maintains $223 → $215 | Strong Buy | Maintains | $223 → $215 | +44.62% | Jan 6, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $269 → $241 | Strong Buy | Maintains | $269 → $241 | +62.10% | Dec 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $258 → $225 | Strong Buy | Maintains | $258 → $225 | +51.34% | Dec 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $240 → $230 | Strong Buy | Maintains | $240 → $230 | +54.71% | Dec 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $230 → $221 | Strong Buy | Maintains | $230 → $221 | +48.65% | Dec 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $215 → $195 | Buy | Maintains | $215 → $195 | +31.16% | Dec 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $217 → $234 | Buy | Maintains | $217 → $234 | +57.40% | Dec 16, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $216 → $230 | Buy | Maintains | $216 → $230 | +54.71% | Dec 16, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $225 → $258 | Strong Buy | Maintains | $225 → $258 | +73.54% | Dec 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.